{"SPECIMEN TYPE": "SPECIMEN TYPE Block", "SPECIMEN SITE": "SPECIMEN SITE Breast", "DATE OF COLLECTION": "DATE OF COLLECTION 10 October 2020", "REPORT DATE": "02 Feb 2021", "Biomarker Findings": ["Tumor Mutational Burden - 10 Muts/Mb", "Microsatellite status - MS-Stable", ""], "Genomic Findings": ["For a complete list of the genes assayed, please refer to the Appendix.", "PALB2 S254fs*3 3, splice site 3113+1G>A", "GNA13 K42N - subclonal1", ""], "Tumor Mutational Burden - 10 Muts/Mb": [["Atezolizumab", "Pembrolizumab"], ["Avelumab", "Cemiplimab", "Durvalumab", "Nivolumab", "Nivolumab +", "Ipilimumab"]], "Microsatellite status - MS-Stable": [["Olaparib", "Talazoparib", "p. 4"], ["Niraparib", "Rucaparib", "NCCN category"]]}